Exploring Analyst Estimates for Campbell (CPB) Q4 Earnings, Beyond Revenue and EPS

Wall Street analysts expect Campbell's (CPB) to post quarterly earnings of $0.40 per share in its upcoming report, which indicates a year-over-year decline of 35.5%. Revenues are expected to be $2.15 billion, down 7.3% from the year-ago quarter.

The consensus EPS estimate for the quarter has been revised 2.4% lower over the last 30 days to the current level. This reflects how the analysts covering the stock have collectively reevaluated their initial estimates during this timeframe.

Prior to a company's earnings release, it is of utmost importance to factor in any revisions made to the earnings projections. These revisions serve as a critical gauge for predicting potential investor behaviors with respect to the stock. Empirical studies consistently reveal a strong link between trends in earnings estimate revisions and the short-term price performance of a stock.

While investors typically rely on consensus earnings and revenue estimates to gauge how the business may have fared during the quarter, examining analysts' projections for some of the company's key metrics often helps gain a deeper insight.

Bearing this in mind, let's now explore the average estimates of specific Campbell metrics that are commonly monitored and projected by Wall Street analysts.

Analysts' assessment points toward 'Net Sales- Meals & Beverages' reaching $1.19 billion. The estimate indicates a year-over-year change of -1.1%.

The consensus among analysts is that 'Net Sales- Snacks' will reach $954.75 million. The estimate indicates a change of -14.7% from the prior-year quarter.

Analysts forecast 'Operating Earnings- Meals & Beverages' to reach $175.84 million. The estimate compares to the year-ago value of $200.00 million.

The consensus estimate for 'Operating Earnings- Snacks' stands at $99.38 million. Compared to the current estimate, the company reported $159.00 million in the same quarter of the previous year.

Shares of Campbell have experienced a change of +6.4% in the past month compared to the +3.9% move of the Zacks S&P 500 composite. With a Zacks Rank #4 (Sell), CPB is expected to underperform the overall market in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .

Zacks' Research Chief Names "Stock Most Likely to Double"

Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.

This top pick is a little-known satellite-based communications firm. Space is projected to become a trillion dollar industry, and this company's customer base is growing fast. Analysts have forecasted a major revenue breakout in 2025. Of course, all our elite picks aren't winners but this one could far surpass earlier Zacks' Stocks Set to Double like Hims & Hers Health, which shot up +209%.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research